Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Juxtapid
Pharma
Judge orders Aegerion to pay patients for Juxtapid missteps
Aegerion admitted in court that it touted its cholesterol med Juxtapid for patients with a disease it wasn't approved to treat.
Tracy Staton
Jan 31, 2018 8:50am
Judge rejects Aegerion's $36M Juxtapid settlement with DOJ
Nov 21, 2017 11:00am
Aegerion risked patient safety with Juxtapid marketing, feds say
Sep 25, 2017 12:13pm
Cash-strapped Aegerion scouts for deals to recover from financial hits
May 19, 2016 10:19am
